Long‐term safety and activity of NY-ESO‐1 SPEAR T cells after autologous stem cell transplant for myeloma

This study in patients with relapsed, refractory, or high-risk multiple myeloma (MM) evaluated the safety and activity of autologous T cells engineered to express an affinity-enhanced T-cell receptor (TCR) that recognizes a peptide shared by cancer antigens New York esophageal squamous cell carcinom...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Blood Adv
Asıl Yazarlar: Stadtmauer, Edward A., Faitg, Thomas H., Lowther, Daniel E., Badros, Ashraf Z., Chagin, Karen, Dengel, Karen, Iyengar, Malini, Melchiori, Luca, Navenot, Jean-Marc, Norry, Elliot, Trivedi, Trupti, Wang, Ruoxi, Binder, Gwendolyn K., Amado, Rafael, Rapoport, Aaron P.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society of Hematology 2019
Konular:
Gene Therapy
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6616263/
https://ncbi.nlm.nih.gov/pubmed/31289029
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2019000194
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller